维普中文期刊产品整合服务
12篇 您的检索式:作者名="REDFIELD ROBERT"
    题名 作者 年代 出处 被引量
1Memorandum on the Study of Acculturation显示文摘REDFIELD ROBERT M HERSKOVITS 1936American Anthropologist1936,38,:1
2The Folk Society显示文摘Robert Redfield 1947American Journal of Sociology1947,,52:1
3The Primitive World View 显示文摘Robert Redfield 1952Pro- ceedings of American Philosophical Society1952,,96:1
4The Folk Society显示文摘Robert Redfield 1947American Journal of Sociology1947,,52:1
5The Social Organization of Tradition显示文摘Redfield Robert 1955The Far Eastern Quarterly 151955,,:1
6The Folk Society显示文摘Redfield Robert 1947American Journal of Sociology1947,41,4:1
7Latent Toxoplasma gondii Infection and Associated Risk Factors among HIV-Infected Individuals at Arba Minch Hospital, South Ethiopia显示文摘Tsegaye Yohanes Serkadis Debalke Endalew Zemene Robert R. Redfield 2014AIDS Research and Treatment2014,,:1
8Randomized, Double-Blind, Placebo-Controlled Study of Sitaxsentan to Improve Impaired Exercise Tolerance in Patients With Heart Failure and a Preserved Ejection Fraction显示文摘Michael R. Zile Robert C. Bourge Margaret M. Redfield Duo Zhou Catalin F. Baicu William C. Little 2014JACC: Heart Failure2014,,2:1
9Incidence of Pancreatitis in HIV-1-Infected Individuals Enrolled in 20 Adult AIDS Clinical Trials Group Studies: Lessons Learned显示文摘Ronald B Reisler Robert L Murphy Robert R Redfield Robert A Parker 2005JAIDS Journal of Acquired Immune Deficiency Syndromes2005,,2:1
10MEMORANDUM FOR THE STUDY OF ACCULTURATION显示文摘Redfield Robert Linton Ralph Herskovits Melville 0,,01:1
11Approaches to antiretroviral therapy in China显示文摘China has recognized the threat of HIV to its population and responded with a national antiretroviral treatment (ART) program. However, high ART failure rates and the spread of resistance within populations are important realities to consider when developing and managing ART programs in China and worldwide. Concepts which will define treatment success and local and national programmatic goals are 1) access to ART, 2) durability of ART at the patient level, 3) scalability of treatment modalities, and the 4) sustainability of the program at the community or national level. In the face of limited resources, China must also consider when to start ARV therapy, which agents to use, when to switch them, and how to treat highly experienced patients with drug resistance. The optimal ARV regimen to start with is changing frequently with the introduction of new agents and the presentation of new data. Currently, a regimen including tenofovir, emtricitabine or lamivudine and a nonnucleoside reverse transcriptase inhibitor appears to have optimal characteristics to treat HIV/AIDS in China. However, critical to all of these choices is the evaluation of programs implemented to insure wide scale success. China has wisely begun this process of evaluating the perfor- mance of local programs through systematic monitoring and evaluation of treatment outcomes. This will allow regi- mens and programs that work to be expanded, and programs with high failure rates to be eliminated. In the end, evidence based data supporting treatment strategies will allow China to successfully confront its AIDS epidemic early and prevent its tragicBruce L GILLIAM Robert R REDFIELD 2005Cell Research2005,15,11:0
12Commentary on “Prevalence and evolution of drug resistance HIV-1 vari-ants in Henan, China”显示文摘Bruce L GILLIAM Robert R REDFIELD Richard Y ZHAO Robert C GALLO 2005Cell Research2005,15,11:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费